One of the most common and most disruptive drawbacks of existing cancer chemotherapies is the toxic effect of bone marrow suppression that can result from a patient’s exposure to ionized radiation. The loss of red blood cells, white blood cells and platelets can cause anemia, fatigue and can increase the risk of infection, among other […]
North Carolina biotechnology company G-Zero Therapeutics aims to develop a pill that people can take to protect against the harmful effects of chemotherapy and radiation exposure. The Chapel Hill-based company now has a $3 million federal grant to advance its work. G-Zero, a spinout from the University of North Carolina at Chapel Hill, received the […]
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.